MEMOLI, BRUNO
 Distribuzione geografica
Continente #
AS - Asia 2.147
NA - Nord America 1.961
EU - Europa 1.512
SA - Sud America 344
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.010
Nazione #
US - Stati Uniti d'America 1.870
SG - Singapore 1.273
RU - Federazione Russa 823
CN - Cina 388
BR - Brasile 271
HK - Hong Kong 196
IT - Italia 183
VN - Vietnam 171
FI - Finlandia 100
IE - Irlanda 93
DE - Germania 75
UA - Ucraina 69
NL - Olanda 64
CA - Canada 58
GB - Regno Unito 47
AR - Argentina 32
IN - India 27
MX - Messico 22
SE - Svezia 18
CI - Costa d'Avorio 16
BD - Bangladesh 15
JP - Giappone 12
TR - Turchia 11
EC - Ecuador 10
ID - Indonesia 9
IQ - Iraq 9
ZA - Sudafrica 9
CO - Colombia 8
ES - Italia 8
PL - Polonia 8
PY - Paraguay 8
PE - Perù 7
UZ - Uzbekistan 6
FR - Francia 5
SA - Arabia Saudita 5
BE - Belgio 4
PK - Pakistan 4
TW - Taiwan 4
IR - Iran 3
KE - Kenya 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
KG - Kirghizistan 2
NP - Nepal 2
SV - El Salvador 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GF - Guiana Francese 1
GM - Gambi 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MU - Mauritius 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YT - Mayotte 1
ZM - Zambia 1
Totale 6.010
Città #
Singapore 588
Chandler 248
Moscow 201
Hong Kong 191
Santa Clara 163
Ashburn 136
Beijing 121
Princeton 82
Jacksonville 69
Boston 64
Millbury 64
Amsterdam 61
Ho Chi Minh City 60
Nanjing 58
Los Angeles 50
Napoli 42
Buffalo 37
Wilmington 37
The Dalles 36
Ann Arbor 33
Ottawa 32
San Jose 32
Dong Ket 28
New York 28
Redondo Beach 25
Hanoi 24
São Paulo 23
Menlo Park 19
Nanchang 19
Houston 18
Hefei 16
Dallas 15
Helsinki 15
Des Moines 14
Munich 14
Jiaxing 13
Orem 13
Hebei 12
Shenyang 12
Woodbridge 12
London 11
Brasília 9
Brooklyn 9
Chicago 9
Da Nang 9
Lallio 9
Norwalk 9
Tokyo 9
Falkenstein 8
Mexico City 8
Montreal 8
Naples 8
Denver 7
Dublin 7
Poplar 7
Porto Alegre 7
Rome 7
San Francisco 7
Seattle 7
Augusta 6
Belo Horizonte 6
Falls Church 6
Greifswald 6
Ninh Bình 6
Rio de Janeiro 6
Tianjin 6
Turku 6
Warsaw 6
Ankara 5
Atlanta 5
Boardman 5
Changsha 5
Charlotte 5
Dhaka 5
Guayaquil 5
Johannesburg 5
Phoenix 5
San Mateo 5
Stockholm 5
Tashkent 5
Washington 5
Weifang 5
Asunción 4
Bengaluru 4
Blumenau 4
Buenos Aires 4
Campinas 4
Chennai 4
Courcelles 4
Hangzhou 4
Lima 4
Manchester 4
Nuremberg 4
Orange 4
Quito 4
Ribeirão Preto 4
Thái Bình 4
Toronto 4
Abidjan 3
Berazategui 3
Totale 3.074
Nome #
Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: A randomized clinical trial 148
Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients? 146
Body composition and cardiovascular risk factors in pretransplant hemodialysis patients 121
Plasma p-Cresol Lowering Effect of Sevelamer in Peritoneal Dialysis Patients: Evidence from a Cross-Sectional Observational Study. 121
Imaging of the peritoneum evaluated by 99mTc-icodextrin scintigraphy in peritoneal dialysis patients: preliminary data 120
Body mass index and survival differences in dialysis patients 118
Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. 114
CHANGES OF SERUM ALBUMIN AND C-REACTIVE PROTEIN ARE RELATED TO CHANGES OF INTERLEUKIN 6 RELEASE BY PERIPHERAL BLOOD MONONUCLEAR CELLS IN HEMODIALYSIS PATIENTS TREATED WITH DIFFERENT MEMBRANES. 113
ROLE OF HFR CARTRIDGE IN THE REMOVAL OF MEDIATORS OF INFLAMMATION IN HEMODIALYSIS PATIENTS 111
Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. 107
Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis 106
Dietary Intake as a Link between Obesity, Systemic Inflammation, and the Assumption of Multiple Cardiovascular and Antidiabetic Drugs in Renal Transplant Recipients. 99
Effects of a diet rich in N-3 polyunsaturated Fatty acids on systemic inflammation in renal transplant recipients. 99
Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data 97
Nutritional intervention in a hemodialysis pregnant woman: a case report 95
Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin. 92
Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia. 89
Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor 88
Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells. 87
: Low dose dopamine induces early recovery of recombinant Interleukin-2 impaired renal function. 86
Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. 85
Membrane distillation of human plasma ultrafiltrate and its theoretical applications to haemodialysis techniques. 83
Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients. 82
EARLY IMPAIRMENT OF RENAL HEMODYNAMIC RESERVE IN PATIENTS WITH ASYMPTOMATIC HEART FAILURE IS RESTORED BY ANGIOTENSIN II ANTAGONISM. 81
Effect of maintenance treatment with mycophenolate mofetil on chronic inflammatory status in proliferative lupus nephritis 81
Stop Flow in abdominal and pelvic cancer relapses. 80
Comparison of vector and conventional bioelectrical impedance analysis in the optimal dry weight prescription in hemodialysis. 80
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients. 80
In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD 79
Human plasma ultrafiltrate purification by membrane distillation: process optimisation and evaluation of its possible application on-line 79
Loculated fluid collections evidenced by peritoneal scintigraphy. 78
Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor. 76
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. 75
Pleural effusion in peritoneal dialysis: overload or leakage? 74
A translational approach to micro-inflammation in End Stage Renal Disease: molecular effects of low levels of Interleukin 6. 73
Evidence on the prevalence and geographic distribution of major cardiovascular risk factors in Italy. 71
ROLE OF DIFFERENT DIALYSIS MEMBRANES IN THE RELEASE OF INTERLEUKIN 6 SOLUBLE RECEPTOR IN UREMIC PATIENTS. 70
The place of loop diuretics in the treatment of acute and chronic renal failure. 69
INTERLEUKIN 2-INDUCED RENAL DYSFUNCTION IN CANCER PATIENTS IS REVERSED BY LOW-DOSE DOPAMINE INFUSION 68
Human galactosylated membrane bioreactor for the long-term maintenance of liver specific functions 67
Effect of maintenance treatment with mycophenolate mofetil on chronic inflammatory status in proliferative lupus nephritis. 67
Bicarbonate and calcium kinetics in postdilutional hemodiafiltration. 66
Human mature adipocytes express albumin and this expression is not regulated by inflammation. 66
HEMODIALYSIS-RELATED LYMPHOMONONUCLEAR RELEASE OF INTERLEUKIN 12 IN PATIENTS WITH END-STAGE RENAL DISEASE. 64
"Obesity paradox" or a better nutritional status? 64
Efficacy of i.v. torasemide in the treatment of acute and chronic high grade renal failure 64
HEMODIALYSIS-RELATED INDUCTION OF INTERLEUKIN 6 PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS 63
Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. 63
Effect of dialysate sodium concentration on interdialytic increase of potassium. 63
EFFECT OF MAINTENANCE TREATMENT WITH MYCOPHENOLATE MOFETIL ON CHRONIC INFLAMMATORY STATUS IN PROLIFERATIVE LUPUS NEPHRITIS 63
Local activation of interleukin 6 signaling is associated with arteriovenous fistula stenosis in hemodialysis patients. 62
Mycophenolic acid inhibits the phosphorylation of NF-kappaB and JNKs and causes a decrease in IL-8 release in H2O2-treated human renal proximal tubular cells. 61
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion. 61
Cytokine production in standard hemodialysis with a new polyethersulfone membrane: a cross-over study. 61
Acute renal and immunological effects of low-dose cyclosporin in humans. 60
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells. 60
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. 59
Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. 59
Hepatocellular functions of human liver cells in oxygen-permeable membrane device 59
Extra-natriuretic effects of atrial peptide in humans. 58
Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor. 58
Effects of uremia, acetate and bicarbonate dialysis on beta-adrenergic responsiveness as assessed by epinephrine-stimulated adenylate cyclase 58
È L’ERITROPOIETINA SEMPRE CITOPROTETTIVA NEI CONFRONTI DELLO STRESS OSSIDATIVO? 58
INFLAMMATORY EFFECTS OF PERITONEAL DIALYSIS. EVIDENCE OF SYSTEMIC MONOCYTE ACTIVATION. 57
Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphurus homeostasis and progression of atherosclerosis? 57
[Guidelines for dialysis. Replacement therapy for acute renal failure in critically ill patients]. 57
Interleukin-6 production induced in peripheral blood mononuclear cells by a serum factor from IgA nephropathy patients is inhibited in vitro by specific sugars. 56
RENAL FUNCTIONAL RESERVE. ITS SIGNIFICANCE IN NORMAL AND SALT DEPLETION CONDITION. 55
Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. 55
Human hepatocyte functions in a galactosylated membrane bioreactor. 55
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers. 54
Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. 53
Cytokine production in haemodialysis. 53
[The IL-6 soluble receptors in hemodialyzed patients]. 53
Proteomic analysis of peritoneal fluid of patients treated by peritoneal dialysis: effect of glucose concentration. 52
The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment. 50
Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale. 48
Effects of uremia, acetate and bicarbonate dialysis on beta-adrenergic responsiveness as assessed by epinephrine-stimulated adenylate cyclase. 48
Loop diuretics and renal vasodilators in acute renal failure. 47
On the pathophysiology of functional acute renal failure. 47
Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. 45
Il litio come marker del riassorbimento tubulare prossimale 41
Totale 6.088
Categoria #
all - tutte 22.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.505


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 0 0 17 3 18 4 43 30
2021/2022428 7 1 0 0 0 6 5 23 80 47 96 163
2022/2023541 86 53 8 46 62 64 0 54 92 56 15 5
2023/2024263 7 45 23 23 14 18 9 22 0 7 74 21
2024/20251.940 102 120 8 9 59 145 228 103 170 166 678 152
2025/20262.116 366 238 311 372 650 143 36 0 0 0 0 0
Totale 6.088